Editas Medicine Valuation
Is EDIT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EDIT?
Other financial metrics that can be useful for relative valuation.
| What is EDIT's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | US$543.14m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 7.6x |
| Enterprise Value/EBITDA | -0.7x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does EDIT's PS Ratio compare to its peers?
| Company | PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 6.9x | ||
CHRS Coherus BioSciences | 2.3x | 27.5% | US$485.6m |
TSVT 2seventy bio | 5.4x | 18.5% | US$497.4m |
AMRN Amarin | 1.8x | 12.8% | US$657.9m |
MRSN Mersana Therapeutics | 18.2x | 37.7% | US$485.0m |
EDIT Editas Medicine | 27.6x | 30.2% | US$543.1m |
Price to Earnings Ratio vs Industry
How does EDIT's PE Ratio compare vs other companies in the US Biotechs Industry?
Price to Sales Ratio vs Fair Ratio
What is EDIT's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 27.6x |
| Fair PS Ratio | 0.003x |
Price-To-Sales vs Fair Ratio: EDIT is expensive based on its Price-To-Sales Ratio (27.6x) compared to the estimated Fair Price-To-Sales Ratio (0x).
Share Price vs Fair Value
What is the Fair Price of EDIT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$8.05 | US$13.06 +62.2% | 45.7% | US$30.00 | US$7.00 | n/a | 17 |
| Mar ’24 | US$8.72 | US$13.06 +49.8% | 45.7% | US$30.00 | US$7.00 | n/a | 17 |
| Feb ’24 | US$10.41 | US$14.24 +36.7% | 59.1% | US$36.00 | US$7.00 | n/a | 17 |
| Jan ’24 | US$8.87 | US$16.38 +84.6% | 74.1% | US$50.00 | US$7.00 | n/a | 16 |
| Dec ’23 | US$10.06 | US$17.27 +71.6% | 70.8% | US$50.00 | US$7.00 | n/a | 15 |
| Nov ’23 | US$12.75 | US$28.93 +126.9% | 69.0% | US$80.00 | US$8.00 | n/a | 15 |
| Oct ’23 | US$12.24 | US$30.00 +145.1% | 64.8% | US$80.00 | US$8.00 | n/a | 15 |
| Sep ’23 | US$15.42 | US$30.86 +100.1% | 64.3% | US$80.00 | US$8.00 | n/a | 14 |
| Aug ’23 | US$15.84 | US$31.07 +96.2% | 64.7% | US$80.00 | US$8.00 | n/a | 14 |
| Jul ’23 | US$12.59 | US$31.07 +146.8% | 64.7% | US$80.00 | US$8.00 | n/a | 14 |
| Jun ’23 | US$10.97 | US$31.07 +183.2% | 64.7% | US$80.00 | US$8.00 | n/a | 14 |
| May ’23 | US$13.24 | US$35.00 +164.4% | 57.5% | US$80.00 | US$10.00 | n/a | 14 |
| Apr ’23 | US$20.22 | US$35.71 +76.6% | 56.8% | US$80.00 | US$10.00 | n/a | 14 |
| Mar ’23 | US$17.49 | US$35.71 +104.2% | 56.8% | US$80.00 | US$10.00 | US$8.72 | 14 |
| Feb ’23 | US$19.69 | US$49.14 +149.6% | 40.8% | US$80.00 | US$16.00 | US$10.41 | 14 |
| Jan ’23 | US$26.55 | US$52.07 +96.1% | 37.8% | US$81.00 | US$18.00 | US$8.87 | 14 |
| Dec ’22 | US$30.41 | US$52.07 +71.2% | 37.8% | US$81.00 | US$18.00 | US$10.06 | 14 |
| Nov ’22 | US$38.61 | US$52.21 +35.2% | 37.4% | US$81.00 | US$19.00 | US$12.75 | 14 |
| Oct ’22 | US$39.91 | US$53.08 +33.0% | 37.7% | US$81.00 | US$19.00 | US$12.24 | 13 |
| Sep ’22 | US$66.66 | US$50.75 -23.9% | 37.3% | US$81.00 | US$22.00 | US$15.42 | 12 |
| Aug ’22 | US$41.86 | US$44.64 +6.6% | 42.2% | US$81.00 | US$20.00 | US$15.84 | 11 |
| Jul ’22 | US$56.52 | US$44.64 -21.0% | 42.2% | US$81.00 | US$20.00 | US$12.59 | 11 |
| Jun ’22 | US$34.22 | US$44.70 +30.6% | 44.2% | US$81.00 | US$20.00 | US$10.97 | 10 |
| May ’22 | US$37.01 | US$49.38 +33.4% | 39.8% | US$81.00 | US$20.00 | US$13.24 | 8 |
| Apr ’22 | US$42.83 | US$51.13 +19.4% | 34.1% | US$81.00 | US$30.00 | US$20.22 | 8 |
| Mar ’22 | US$46.89 | US$50.14 +6.9% | 36.8% | US$81.00 | US$30.00 | US$17.49 | 7 |